1.
Get more info on this report!
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and
Performance Enhancers)
May 1, 2009
The multi-billion veterinary health products market, though smaller in opportunity as
compared with the human health sector, offers significant return on investment,
primarily driven by lower risk and faster product development cycles. The veterinary
health products market has remained resilient over the economic downturns of the past
2 decades.
This report, World Veterinary Health Products, takes a look at veterinary health
products for both companion (pet) animals, and production animals (livestock and
poultry) and the opportunity for existing players and new entrants in three segments:
• Pharmaceuticals (including Parasiticides, Anti-infectives, NSAIDS,
Cardiovasculars, Hormones, CNS, Others)
• Veterinary (Pet) OTC Products (Parasiticides, NSAIDS, Vitamins, GI Disorders,
Cold and Cough, Others)
• Performance Enhancers
• Veterinary Vaccines
For each segment, the report includes pet and production animal demographic
information, market forecasts to 2014, major products in the industry, trends affecting
business planning, and competitive activity. Revenues are provided for U.S., Europe
and Rest of World. This report profiles the following key companies in this industry: This
report profiles the following key companies in this industry:
• Alpharma Animal Health
• Adisseo France S.A.S.
• BASF International
• Bayer Healthcare
• Boehringer Ingelheim GmbH
• DSM Nutritional Products, Inc.
• Elanco Animal Health
• Fort Dodge Animal Health

2. • Heska Corporation
• Intervet Schering Plough Animal Health
• Merial Animal Health Ltd.
• Novartis Animal Health Inc.
• Virbac SA
• Pfizer Animal Health
This report was constructed with secondary research into annual reports, government
health data, trade and medical journals, supplemented with phone and email interviews
with executives and experts in the industry. Interviews were used to test assumptions
and fix forecasts in the report.
Table of Contents
CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET- STRATEGIC
PERSPECTIVES
1.1. A Resilient Market, Even in Downturns
1.2. Epidemiology
Livestock
Pets
1.3. Veterinary Health Products Industry Structure
1.3.1. Key Factors Affecting the Industry
a) Threat of Generics
b) Lack of innovation
c) Expectations
d) High dependence on the product
1.4. Market
1.5. Market Segments
1.5.1 Companion Animal Products (CAP)
a) Pet Insurance Market
1.5.2. Food Animal Products (FAP)
a) Leading Growth Drivers
1.6. Customer Segments

3. a) Veterinary Hospitals
b) Farms
c) Pet Owners
1.7. Market Size and Growth
1.8. Market Segments
1.8.1. Veterinary Pharmaceuticals Market
1.8.2. Veterinary Vaccines Market
1.8.3. Veterinary Performance Enhancers Market
1.9. Geography
1.10. Species
1.11. Competition
1.12. Mergers and Acquisitions
1.13. Research and Development
a) Leading R&D trends in the Animal Health Industry
1.14. Future Industry trends for Growth
a) Shift from product to market focus
b) Enhanced focus on R&D
c) Consolidation and Globalization
CHAPTER TWO: VETERINARY PHARMACEUTICAL PRODUCTS MARKET
2.1. Background
a) Preventative medicines
b) Therapeutic Medicines
c) Others
2.2. Market Size and Growth
2.3. Market Segments
2.3.1. Veterinary Anti-Infective Market
2.3.2. Veterinary Anti-inflammatory Products Market

4. 2.3.3. Veterinary Cardiovascular Products Market
2.3.4. Veterinary Parasiticidal Products Market
2.3.5. Veterinary CNS disorders Products Market
2.3.6. Veterinary Hormonal Products Market
2.4. Competition
2.5. Leading Market Trends
a) Generics threat
b) New technologies and innovations
c) New geographical market growth
CHAPTER THREE: VETERINARY VACCINES MARKET
3.1. Background
3.2. Veterinary Diseases & Vaccination
3.2.1. Vaccine Types
a) Live vaccines
b) Dead vaccines
3.2.2. Livestock Vaccination
a) Cattle Vaccines
b) Sheep Vaccines
c) Goat Vaccines
d) Pig Vaccines
e) Swine Vaccines
3.2.3. Pet vaccines
a) Background
b) Current guidelines
3.2.4. Poultry vaccines
3.3. Vaccination Advantages
a) Cost containment

5. b) Reduction in antibiotic use
c) Improvement in human health
d) Impact on the industry
e) Good Health, consistent throughput
3.4. Disease costs
3.5. Vaccine development
a) Development Process
b) Equipment
3.6. Vaccination Guidelines
3.7. Market Size and Growth
3.8. Geographical split
3.9. Competitive Share
a) Demand Drivers: Positive Factors
b) Demand: Negative Factors
3.10. Hurdles in Vaccine Development
a) Biological and technical obstacles
b) Economic obstacles
c) Target complexity and diversity
3.11. Regulatory Aspects
3.12. International Cooperation on Harmonization Guidelines for Vaccines
3.13. Procedures for licensing veterinary vaccines
a) Japan
b) United States of America
c) European Union
3.14. Future Trends
a) Emerging diseases
b) New vaccine technologies

6. CHAPTER FOUR: VETERINARY PERFORMANCE ENHANCERS PRODUCTS
MARKET
4.1. Background
4.2. Feed Additives
4.2.1. Feed Composition
4.2.2. Nutritional Feed Additives
a) Amino acids
b) Vitamins
c) Organic acids
4.2.3. Medicated Feed Additives
a) Enzymes
b) Prebiotics, Probiotics
c) Hormones
4.2.4. Feed Additives: Advantages
a) Improve animal diet.
b) Provide therapeutic benefit and reduce cost.
c) Increase feed conversion efficiency thereby leading to improved profitability.
4.3. Market size and growth
4.3.1. Market Growth Drivers
4.4. Market Segments
4.4.1. Nutritional Feed Additives Market
a) Amino acids
b) Vitamins
c) Organic Acids
4.4.2. Medicated Feed Additives Market
a) Antibiotics
b) Probiotics and Prebiotics
c) Enzymes

7. d) Anti-protozoal agents
4.4.2.1. Medicated Feed Additives: By Species (Poultry, Pigs, Cattle, Others),
2008
4.5. Geographical Split
4.6. Competition
4.7. Implants and Injections
4.7.1. Market Size and Growth
4.8. Regulatory Framework
a) US
b) Europe
4.9. Safety Issues
CHAPTER FIVE: VETERINARY OTC PRODUCTS MARKET
5.1. Background
5.2. Pet population trends
a) Greying human populace
b) Increasing life expectancy of pets
c) Advantages
5.3. Market Size and Growth
5.4. Market Segments
5.5. Market Drivers
a) Rising pet ownership
b) Consumer behavior
c) Rx-to-OTC switch
d) Product quality
e) Price sensitivity
f) Improving distribution network
g) Increasing focus on Wellness
5.6. Product Life-cycle Management

8. a) Broad customer group
b) New formulations
c) Creative marketing strategies
d) Distribution Structure
5.7. Regulatory Issues
CHAPTER SIX: CORPORATE PROFILES
6.1. Alpharma Animal Health
Background
Products
Revenues
Business Strategy
6.2. Adisseo France S.A.S.
Background
Products
Business Strategy
Revenues
6.3. BASF International
Background
Products
Revenues
6.4. Bayer Healthcare
Background
Products
Revenues
6.5. Boehringer Ingelheim GmbH
Background
Products

9. Revenues
6.6. DSM Nutritional Products, Inc.
Background
Products
Revenues
6.7. Elanco Animal Health
Background
Products
Revenues
6.8. Fort Dodge Animal Health
Background
Products
Revenues
6.9. Heska Corporation
Background
Products
Revenue
6.10. Intervet Schering Plough Animal Health
Background
Products
Products
Revenues
6.11. Merial Animal Health Ltd.
Background
Products
Revenues
6.12. Novartis Animal Health Inc.

10. Background
Products
Farm animal products
Livestock animal products
6.13. Virbac SA
Background
Revenues
Products
6.14. Pfizer Animal Health
Background
Products
Revenues
LIST OF EXHIBITS
CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET STRATEGIC
PERSPECTIVES
Exhibit 1: Worldwide Livestock Population, 2008
Exhibit 2: Worldwide Pet population, 2008
Exhibit 3: Market Share: Companion Animal vs. Food Production Animal
Exhibit 4: Worldwide Companion Animal Prescriptions and Vaccines Market,
2008
Exhibit 5: US Household Penetration of Pets (%), 2008
Exhibit 6: Worldwide Veterinary Health Products Market
Exhibit 7: Worldwide Veterinary Health Products Market: Market Segments ($
billion) and Growth (%) (2006-14)
Exhibit 8: Worldwide Veterinary Health Products Market:
Exhibit 9: Worldwide Veterinary Pharmaceuticals Market:
Exhibit 10: Worldwide Veterinary Pharmaceutical Products Market, 2006-14
Exhibit 11: Worldwide Veterinary Vaccines Market:
Exhibit 12: Veterinary Vaccines Market, 2006-14

11. Exhibit 13: Worldwide Veterinary Performance Enhancer Products Market:
Exhibit 14: Veterinary Performance Enhancers Market, 2006-14
Exhibit 15: Regional Share Break-up (%), 2008
Exhibit 16: Worldwide Veterinary Health Products Market:
Exhibit 17: Worldwide Veterinary Health Products Market by Region:
Exhibit 18: Veterinary Health Products Market by Species, 2008 (Ruminants,
Pigs, Poultry, Companions, Others)
Exhibit 19: Veterinary Health Products Market: Leading Companies, 2008
Exhibit 20: Veterinary Health Products Industry: Mergers and Acquisitions Trends
CHAPTER TWO: VETERINARY PHARMACEUTICAL PRODUCTS MARKET
Exhibit 21: Veterinary Pharmaceutical Products Market, 2006-14 (US, Europe,
ROW)
Exhibit 22: Veterinary Pharmaceutical Products Market, 2006-14 (US, Europe,
ROW)
Exhibit 23: Veterinary Pharmaceutical Products Market, 2006-14 (Parasiticides,
Anti-infectives, NSAIDS, Cardiovasculars, Hormones, CNS, Others)
Exhibit 24: Veterinary Pharmaceutical Products Market: Segment Share %, 2008
Exhibit 25: Generic vs. Branded Products 2008
Exhibit 26: Veterinary Anti-infective Products Market by Region (US, Europe,
ROW), 2006-14
Exhibit 27: Veterinary Anti-inflammatory Products Market by Region (US, Europe,
ROW), 2006-14
Exhibit 28: Veterinary Cardiovascular Products Market by Region (US, Europe,
ROW), 2006-14
Exhibit 29: Veterinary Parasiticidal Products Market Veterinary Implants Market
by Region (US, Europe, ROW), 2008-14
Exhibit 30: Veterinary CNS Disorders Products Market by Region (US, Europe,
ROW), 2006-14
Exhibit 31: Veterinary Hormone Products Market by Region (US, Europe, ROW),
2006-14
Exhibit 32: Veterinary Pharmaceutical Products Market Share
CHAPTER THREE: VETERINARY VACCINES MARKET

12. Exhibit 33: Trade of Livestock in Millions of Tons (Beef, Pork, Poultry) 2001-2014
Exhibit 36: Disease Outbreak: Direct versus Indirect cost comparison
Exhibit 34: Veterinary Vaccines Market by Region (US, Europe, ROW), 2006-14
Exhibit 35: Veterinary Vaccines Market by Region (US, Europe, ROW), 2006-14
Exhibit 36: Veterinary Vaccines Market by Region (USA, Europe, ROW)
Exhibit 37: Veterinary Vaccine Sales by Species (Livestock, Poultry, Other)
Exhibit 38: Veterinary Vaccines, Competitive Share, 2008
CHAPTER FOUR: VETERINARY PERFORMANCE ENHANCERS PRODUCTS
MARKET
Exhibit 40: Veterinary Performance Enhancers Market, 2006-14
Exhibit 41: Veterinary Performance Enhancers: Segment Share(Medicated Feed
Additives, Nutritional Feed Additives, Implants and Injections), 2008
Exhibit 42: Worldwide Nutritional Feed Additives Market(Amino Acids, Vitamins,
Organic Acids), 2006-14
Exhibit 43: Veterinary Nutritional Feed Additives: Segment Share, 2008
Exhibit 44: Worldwide Medicated Feed Additives Market (Antibiotics, Enzymes,
Probiotics and Prebiotics, Anti-protozoals), 2006-14
Exhibit 45; Worldwide Medicated Feed Additives: Segment Share, 2008
Exhibit 46: Veterinary Performance Enhancers Market, Competitive Share, 2008
Exhibit 47: Veterinary Feed Additives Market by Geography (US, Europe, ROW),
2008
Exhibit 48: Veterinary Performance Enhancers Market, Competitive Share, 2008
Exhibit 49: Veterinary Implants Market by Region (US, Europe, ROW), 2006-14
Exhibit 50: Veterinary Implants Market by Region (US, Europe, ROW), 2006-14
CHAPTER FIVE: VETERINARY OTC PRODUCTS MARKET
Exhibit 51: Pet Population (Dogs, Cats Rabbits, Horses) by Region (US, Europe,
Global) 2008
Exhibit 52: Veterinary OTC Health Products Market, 2006-14
Exhibit 53:Veterinary OTC Health Products Market
Exhibit 54: Veterinary OTC Health Products Market by Segments (Parasiticides,
NSAIDS, Vitamins, GI Disorders, Cold and Cough, Others) 2006-14

13. Exhibit 55: US Household Pet Ownership (Dogs, Cats, Birds, Horses)
Available immediately for Online Download at
http://www.marketresearch.com/product/display.asp?productid= 1829596
US: 800.298.5699
UK +44.207.256.3920
Int'l: +1.240.747.3093
Fax: 240.747.3004